RNF168 and cancer: The TCGA papers provide essential data demonstrating the increased expression of RNF168 in HPV+ cancers, which provides important insight into how HPV proteins may subvert DSB signaling and repair pathways, potentially highlighting novel therapeutic avenues in these cancers.